Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Omkar Pharmachem Ltd.
Swot
Omkar Pharmachem Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Omkar Pharmachem Ltd. has 15 Strengths, 7 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(7)
Opportunity
(0)
Threats
(0)
Others
(4)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Biggest Price Gainers from Open
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
New 52 week low today
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Near 52 Week Low
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Bullish or Bearish Candlestick Strength - Indices
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
New 52 Week Low
